DK0719276T3 - Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf - Google Patents

Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf

Info

Publication number
DK0719276T3
DK0719276T3 DK94928126T DK94928126T DK0719276T3 DK 0719276 T3 DK0719276 T3 DK 0719276T3 DK 94928126 T DK94928126 T DK 94928126T DK 94928126 T DK94928126 T DK 94928126T DK 0719276 T3 DK0719276 T3 DK 0719276T3
Authority
DK
Denmark
Prior art keywords
well
pharmaceutical preparations
preparations containing
estradiol esters
oral action
Prior art date
Application number
DK94928126T
Other languages
Danish (da)
English (en)
Inventor
Richard P Blye
Gabriel Bialy
Hyun K Kim
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0719276T3 publication Critical patent/DK0719276T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94928126T 1993-09-17 1994-09-15 Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf DK0719276T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/122,853 US5554603A (en) 1993-09-17 1993-09-17 Orally active derivatives of 1,3,5(10)-estratriene
PCT/US1994/010393 WO1995007925A1 (en) 1993-09-17 1994-09-15 Orally active derivatives of 1,3,5(10)-estratriene

Publications (1)

Publication Number Publication Date
DK0719276T3 true DK0719276T3 (da) 1998-08-10

Family

ID=22405185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928126T DK0719276T3 (da) 1993-09-17 1994-09-15 Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf

Country Status (11)

Country Link
US (1) US5554603A (ja)
EP (1) EP0719276B1 (ja)
JP (1) JP3993228B2 (ja)
AT (1) ATE160573T1 (ja)
AU (1) AU700576B2 (ja)
CA (1) CA2171740C (ja)
DE (1) DE69407057T2 (ja)
DK (1) DK0719276T3 (ja)
ES (1) ES2110258T3 (ja)
GR (1) GR3025872T3 (ja)
WO (1) WO1995007925A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en) 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
AU2004237574A1 (en) * 2003-03-13 2004-11-18 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
WO2005116047A2 (en) * 2004-05-27 2005-12-08 Migenix Corp. 2-substituted 17-imino estrogen compounds for cytoprotection
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
KR101828619B1 (ko) * 2010-03-28 2018-02-12 이브스트라, 인코포레이티드 질 내 약물 전달 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1074493A (en) * 1963-06-12 1967-07-05 Roussel Uclaf Novel estrane derivatives and processes for preparing them
FR5241M (ja) * 1966-02-24 1967-07-17
NL135316C (ja) * 1966-11-18
US3980681A (en) * 1969-11-21 1976-09-14 Peter Job Sykes Process for the preparation of 11-β-nitro-oxysteroids
GB1332784A (en) * 1969-11-21 1973-10-03 Glaxo Lab Ltd Nitrates of steroid 11 beta-ols
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes

Also Published As

Publication number Publication date
DE69407057T2 (de) 1998-04-09
EP0719276A1 (en) 1996-07-03
ATE160573T1 (de) 1997-12-15
GR3025872T3 (en) 1998-04-30
ES2110258T3 (es) 1998-02-01
US5554603A (en) 1996-09-10
AU700576B2 (en) 1999-01-07
JP3993228B2 (ja) 2007-10-17
DE69407057D1 (de) 1998-01-08
EP0719276B1 (en) 1997-11-26
CA2171740C (en) 2005-07-26
CA2171740A1 (en) 1995-03-23
WO1995007925A1 (en) 1995-03-23
JPH09505802A (ja) 1997-06-10
AU7728494A (en) 1995-04-03

Similar Documents

Publication Publication Date Title
NL193616B (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
IL87885A (en) Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
TW272195B (ja)
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL109901A (en) Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them
AU674378B2 (en) Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
HUT41002A (en) Process for preparing anticonvulsives
ZA929879B (en) Compositions for the treatment of mammalian diseases.
TW218011B (ja)
PT83253A (en) Process for preparing p-acylaminobenzamides
TR25423A (tr) DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI.
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
IL101540A0 (en) Method and composition for the treatment of herpes related disorders
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.